|
HS Code |
843303 |
| Chemical Name | 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride |
| Molecular Formula | C9H14ClNO2 |
| Molecular Weight | 203.67 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Melting Point | 234-238°C (decomposes) |
| Cas Number | 169590-11-4 |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Purity | Typically >98% |
| Synonyms | 2-Methoxy-4-(2-aminoethyl)phenol hydrochloride |
| Iupac Name | 2-methoxy-4-(2-aminoethyl)phenol hydrochloride |
As an accredited 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The 25g quantity of 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride is supplied in a tightly sealed amber glass bottle. |
| Shipping | **Shipping Description:** 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride is shipped in tightly sealed, chemical-resistant containers. It should be kept dry and protected from light. Standard shipment is at ambient temperature, unless specified otherwise. All packaging complies with regional regulations for transport of non-hazardous laboratory chemicals. Safety Data Sheet (SDS) is provided upon request. |
| Storage | Store 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride in a tightly sealed container, away from moisture and incompatible substances. Keep in a cool, dry, and well-ventilated area, protected from direct sunlight and heat sources. Ensure storage temperature is between 2–8°C (refrigerated). Label container clearly, and avoid exposure to oxidizing agents. Use appropriate personal protective equipment (PPE) when handling. |
Competitive 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every so often in this business, a molecule demonstrates the right blend of reactivity, solubility, and selectivity for challenging synthesis work. 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride—often known in labs as an essential intermediate for several active pharmaceutical ingredients—has earned that distinction through reliable performance in real-world conditions. Over years of manufacture and scale-up, its consistency and predictable behavior during downstream processing have formed the backbone of countless novel drug discovery efforts.
Producing this compound requires control over every aspect of the reaction sequence. Minor deviations in chlorination, reactor temperature, or acidity levels often bring unwanted side-products that complicate purification and later functionalization. Our facility was built to answer these technical demands with advanced process control along each stage—ensuring each batch falls within a narrow purity window. After several thousand kilograms have moved through our reactors, the analytical feedback loop is now mature: high-resolution HPLC analysis keeps batch-to-batch variation negligible, reducing risk in scale-up, and providing a solid foundation for our customers in both medicinal chemistry and scale manufacturing.
Compared with other phenolic amine derivatives, the methoxy substituent at the 2-position increases electronic stability of the phenol ring and can influence hydrogen bonding in downstream chemistry. The presence of a 2-aminoethyl group imparts a desirable balance between hydrophilicity and reactivity, broadening the scope for both aqueous and organic reactions. The hydrochloride salt appears as a crystalline white solid, which offers improved handling and increased shelf stability, something free base analogues often lack.
In practical applications, our customers find that this molecule allows cleaner coupling to carboxylic acid groups in final API steps. The phenolic oxygen can participate in directed ortho-metalation chemistry, which is valuable for producing analogues with high regioselectivity. Our staff chemists have fielded countless technical support requests from process engineers running kilograms at pilot plant scale; knowing where typical bottlenecks emerge—such as during recrystallization or conversion to final salt forms—lets us provide information that goes beyond the data sheet to share the results of hands-on development.
Testing protocols for 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride hinge on more than just adherence to a certificate of analysis. The byproducts of the synthesis route include O-demethylated analogues and N-dealkylated phenols, both of which interfere during downstream transformations. Our analytical chemists employ HPLC, LC-MS, and NMR to quantify impurity profiles, revising parameters if necessary. After years of optimizing our process, the assay value for the active compound consistently exceeds accepted pharmacopeia guidelines, while residual solvent levels are monitored per ICH Q3C guidance.
Moisture content often challenges the stability of hydrochloride salts in phenolic amines, and we had to rethink packaging after initial market feedback. Today, desiccated packaging and controlled-atmosphere storage prevent clumping and loss in flowability, ensuring the product arrives the same as it left our QC department. Instead of simple labeling, we provide detailed batch records, expiry determination based on real data, and traceability through individualized lot numbers. This approach, while requiring extra compliance documentation, helps our partners satisfy regulatory bodies and streamline their own filing processes.
Most inquiries about 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride involve pharmaceutical synthesis. The compound functions as a critical building block in β-adrenergic receptor ligands, particularly those designed for improved blood-brain barrier penetration. Beyond pharma, some agrochemical researchers use it for the development of enzyme inhibitors, leveraging the unique substitution pattern to create new modes of action. Several research-scale biochemists have shared feedback on its effectiveness as a ligand precursor in analytical methods targeting catecholamine neurotransmitters.
Every batch supports a research goal—sometimes a promising therapy, other times a more efficient process. Where alternative intermediates often suffer from solubility limitations or incompatibility with aqueous phase chemistries, the hydrochloride form delivers consistent results for reactions under acidic or neutral conditions. Over the years, protocol adjustments in solution purification, particularly for downstream acetylation and Boc protection steps, have benefited from our technical white papers and onsite troubleshooting expertise.
Part of our manufacturing philosophy springs from regular conversations with formulation scientists and synthetic chemists—the product’s main audience. Early versions, prepared under standard glass-lined kettles, sometimes picked up unreacted halides or trace impurities linked to solvent choice. Through scaling, we redesigned filtration media to handle higher throughput without sacrificing selectivity, adopted closed transfer lines to protect from moisture ingress, and introduced a chilled storage protocol to retain potency over longer periods.
It took trial and error to optimize granulation for this hydrochloride, which tends to cake if left in ambient humidity. We bypassed the need for anti-caking agents by tightening environmental controls and speeding up batch-to-batch turnover. These technical adjustments often sound minor, but when delivering material for clinical-stage projects, even one day’s delay can mean missing an R&D milestone. Last winter’s supply chain disruptions reaffirmed the wisdom of keeping multiple buffer stocks and building in redundancy for critical reaction inputs.
Scaling up from pilot to commercial production led us to adopt more sensitive trace metal testing. Manufacturing in stainless steel reactors raised concerns over possible contamination; we invested in glass-lined steel units for key synthesis steps. Testing each lot for trace iron and nickel now comes standard, based on customers’ needs for cleaner, more consistent starting materials.
Over the years, we compared performance data for 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride against structurally similar products like 2-methoxy-4-aminophenol and traditional 2-aminophenol hydrochloride. Introducing the aminoethyl side chain opened new chemoselectivity pathways. We noticed a steady increase in interest from medicinal chemistry teams looking to avoid side reactions related to ortho/para reactivity seen in less hindered phenolic amines. It also delivers superior crystallinity and handling compared to related free base compounds, which tend to absorb atmospheric moisture and oxidize during storage.
The product’s low odor, stability under mild heating, and lack of photodegradation have attracted polymer innovators as well. One feedback cycle from a major research customer pointed out that the hydrochloride version eliminated color instability they previously saw during bench-scale compounding. Short shelf life and batch-to-batch inconsistency plagued certain competitor offerings, making our process improvements stand out through real-world testing.
Unlike some intermediates that only suit batch chemical synthesis, this compound’s robust profile supports both lab-scale screening and ton-scale production. Its use has moved from specialized research into semi-commercial campaigns—a transition that only works because each lot participates in full traceability, safety validation, and active technical support.
Synthesis of complex organic molecules requires a deep understanding of safety risks. Our team actively participates in collaborative hazard analyses with clients. This open communication loop has uncovered points of improvement—like modifications to batch quenching techniques and real-time monitoring of reactor gases. More stringent local regulatory requirements have pushed us to provide full impurity profiling, comply with waste minimization strategies, and substitute less hazardous reagents in certain process steps. We offer shared technical documentation and are open with authorities about our procedures and performance data, keeping our process in compliance with both workplace safety and environmental protection regulations.
In the area of occupational health, we review our safety protocols after any new information about related intermediates or synthesis steps emerges in the literature. Training for plant operators covers both incident scenarios and day-to-day exposure controls, anchored by data collected from real annual monitoring. Each improvement, whether a new dust collection system or updated PPE guidelines, comes after discussing needs with those working hands-on in the plant. This culture of direct feedback drives our commitment to keeping production safe at all levels.
Manufacturing specialty chemicals requires dialogue, not just supply. We back each shipment with both technical guidance and on-site visits, answering questions that come up during method transfer or process ramp-up. Whether the issue is a stalled crystallization or an unexpected color change, we keep records of troubleshooting so future batches run more smoothly. Our technical support staff are not call-center agents but are chemists and engineers who know the actual batch records and can compare analytical findings directly with customers’ samples.
Continuous process validation and process capability studies are standard for our operation. We’ve introduced digital control logs and electronic batch history, which makes recall or investigation of historical lots much faster. By sharing our own performance metrics—out-of-spec incident rates, shipping times, compliance audit results—we create transparent expectations. Customers can plan more confidently because they understand how we manage production and what the likely risks may be.
For multinational R&D departments, logistics matter as much as chemistry. We have expanded warehouse capabilities near key port cities and now manage buffer inventory for annual contracts. This avoids the peaks and valleys that project-based ordering often creates. Our clients have access to the same shipment and inventory data that our logistics staff see—to enhance planning around holidays, plant shutdowns, or regulatory check-points.
Scientific literature has started to reflect the broader potential of this compound. Recent academic publications suggest new cross-coupling reactions and derivatives might play a role in the next generation of CNS therapies and targeted enzyme blockers. Our own R&D team keeps pace, testing new protecting groups and derivatization conditions to help customers fast-track their projects from bench to plant. In a market where regulatory demands have grown and supply chains face increasing scrutiny, reliability and traceability make a difference at every step.
We track industry shifts and adapt as our customers’ needs shift. Some request tighter particle size distributions for specialized solid formulations; others ask about green chemistry initiatives. We have introduced recycling programs for solvent recovery, invested in energy-efficient heating and cooling, and support customer efforts to develop greener downstream routes.
The team behind our 4-(2-Amino-Ethyl)-2-Methoxy-Phenol Hydrochloride builds on both technical know-how and direct industry experience. Instead of focusing on features, our approach centers on the practical benefits our clients gain in their laboratories and plants. Longevity in this field does not stem from marketing language or buzzwords—our credibility rests on performance, resilience under stress, and day-to-day contact with those advancing science at the bench.
We see our work as a partnership, each batch a step toward safer, more efficient, and more innovative chemistry. Our customers’ feedback never falls on deaf ears. Each process improvement, specification adjustment, or documentation enhancement builds from conversations with scientists who depend on our products in the real world.